scholarly journals Correction to: Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial

2020 ◽  
Vol 109 (10) ◽  
pp. 1260-1260
Author(s):  
Alessandro Galluzzo ◽  
Simone Frea ◽  
Paolo Boretto ◽  
Stefano Pidello ◽  
Alessandra Volpe ◽  
...  
Keyword(s):  
Heart Failure ◽  
Advanced Heart Failure ◽  
Urinary Sodium ◽  
Acute Decompensation ◽  
Dilutional Hyponatremia

Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial

2020 ◽  
Vol 109 (10) ◽  
pp. 1251-1259 ◽  
Author(s):  
Alessandro Galluzzo ◽  
Simone Frea ◽  
Paolo Boretto ◽  
Stefano Pidello ◽  
Alessandra Volpe ◽  
...  
Keyword(s):  
Heart Failure ◽  
Advanced Heart Failure ◽  
Urinary Sodium ◽  
Acute Decompensation ◽  
Dilutional Hyponatremia

scholarly journals Pulsed Levosimendan in advanced heart failure due to congenital heart disease: a case series

2020 ◽  
Vol 4 (3) ◽  
pp. 1-6
Author(s):  
James Cranley ◽  
Antonia Hardiman ◽  
Leisa J Freeman
Keyword(s):  
Heart Failure ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Case Series ◽  
Advanced Heart Failure ◽  
Good Evidence ◽  
Case Summary ◽  
Acute Decompensation

Abstract Background Levosimendan is a non-adrenergic calcium-sensitizing agent with positive inotropic and vasodilatory effects. Its use in acute decompensation of heart failure is established. Good evidence now exists for repetitive infusions of Levosimendan to improve symptoms and reduce hospitalization in advanced heart failure (AdHF) populations. Its use in heart failure resulting from congenital heart disease is not yet commonplace. Case summary We present three cases in which pulsed Levosimendan was used in the management of AdHF secondary to underlying congenital heart disease. There was symptomatic and biomarker evidence of improvement. Discussion Intermittent Levosimendan may represent a valuable therapy to reduce hospitalization and improve quality of life in adults with congenital heart conditions.

546 Clinical and neurohormonal correlates of circulating soluble apoptosis markers in decompensated advanced heart failure

2003 ◽  
Vol 2 (1) ◽  
pp. 115-116
Author(s):  
J PARISSIS ◽  
S ADAMOPOULOS ◽  
K VENETSANOU ◽  
D MENTZIKOF ◽  
K KIRANAKOS ◽  
...  
Keyword(s):  
Heart Failure ◽  
Advanced Heart Failure ◽  
Apoptosis Markers
Sign in / Sign up

Export Citation Format

Share Document